RENBP and cancer: Having observed a potent cytotoxicity mediated by NK-CARs and given that the loss of targeted Ag from cancer cells is a major barrier to CAR therapy, we next assessed whether NK-CARs would be effective in eliminating target cells with low Ag levels.